Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 288

1.

Giant cell arteritis.

Levine SM, Hellmann DB.

Curr Opin Rheumatol. 2002 Jan;14(1):3-10. Review.

PMID:
11790989
2.

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JW.

Ann Rheum Dis. 1996 Apr;55(4):218-23. Erratum in: Ann Rheum Dis 1996 Aug;55(8):563.

3.

Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, Martin J.

Drugs Aging. 2006;23(8):627-49. Review.

PMID:
16964987
4.

Diagnosis and treatment of giant cell arteritis.

Cantini F, Niccoli L, Nannini C, Bertoni M, Salvarani C.

Drugs Aging. 2008;25(4):281-97. Review.

PMID:
18361539
5.

Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.

Rodriguez-Valverde V, Sarabia JM, González-Gay MA, Figueroa M, Armona J, Blanco R, Fernández-Sueiro JL, Martínez-Taboada VM.

Am J Med. 1997 Apr;102(4):331-6.

PMID:
9217613
6.

Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Schmidt J, Warrington KJ.

Drugs Aging. 2011 Aug 1;28(8):651-66. doi: 10.2165/11592500-000000000-00000. Review.

PMID:
21812500
7.

[Polymyalgia rheumatica and temporal arteritis].

Vos PA, Bijlsma JW, Derksen RH.

Ned Tijdschr Geneeskd. 2005 Aug 27;149(35):1932-7. Review. Dutch.

PMID:
16159030
8.

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernández-Rodríguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X; International Network for the Study of Systemic Vasculitides.

Arthritis Rheum. 2002 May;46(5):1309-18.

9.

[Value of colour Doppler ultrasonography in relation to clinical pretest probability in giant cell (temporal) arteritis].

Stammler F, Grau C, Schnabel A.

Dtsch Med Wochenschr. 2009 Oct;134(42):2109-15. doi: 10.1055/s-0029-1241899. Epub 2009 Oct 6. German.

PMID:
19809960
10.

Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?

Maksimowicz-McKinnon K, Clark TM, Hoffman GS.

Medicine (Baltimore). 2009 Jul;88(4):221-6. doi: 10.1097/MD.0b013e3181af70c1.

11.

The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritis.

Nuenninghoff DM, Matteson EL.

Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S29-34. Review.

PMID:
14740425
12.

[Giant cell arteritis. A study of 191 patients].

Armona J, Rodríguez-Valverde V, González-Gay MA, Figueroa M, Fernández-Sueiro JL, Blanco R, Martínez-Taboada V.

Med Clin (Barc). 1995 Dec 2;105(19):734-7. Review. Spanish.

PMID:
8523954
13.

Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica.

Salvarani C, Gabriel SE, Gertz MA, Bjornsson J, Li CY, Hunder GG.

Arthritis Rheum. 1994 Nov;37(11):1621-6.

PMID:
7980674
14.

Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.

Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J.

Medicine (Baltimore). 2005 Sep;84(5):269-76.

15.

Disease patterns and tissue cytokine profiles in giant cell arteritis.

Weyand CM, Tetzlaff N, Björnsson J, Brack A, Younge B, Goronzy JJ.

Arthritis Rheum. 1997 Jan;40(1):19-26.

PMID:
9008596
16.

Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?

Chatelain D, Duhaut P, Loire R, Bosshard S, Pellet H, Piette JC, Sevestre H, Ducroix JP.

Arthritis Rheum. 2008 Aug;58(8):2565-73. doi: 10.1002/art.23700.

17.

Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.

Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.

JAMA. 2016 Jun 14;315(22):2442-58. doi: 10.1001/jama.2016.5444. Review.

PMID:
27299619
18.

The diagnosis of giant cell arteritis.

Melson MR, Weyand CM, Newman NJ, Biousse V.

Rev Neurol Dis. 2007 Summer;4(3):128-42. Review.

PMID:
17943065
19.

Clinical features of polymyalgia rheumatica and giant cell arteritis.

Salvarani C, Pipitone N, Versari A, Hunder GG.

Nat Rev Rheumatol. 2012 Sep;8(9):509-21. doi: 10.1038/nrrheum.2012.97. Epub 2012 Jul 24. Review.

PMID:
22825731
20.

Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment.

Borchers AT, Gershwin ME.

Autoimmun Rev. 2012 May;11(6-7):A544-54. doi: 10.1016/j.autrev.2012.01.003. Epub 2012 Jan 21. Review.

PMID:
22285588
Items per page

Supplemental Content

Write to the Help Desk